相关实验视频

Updated: May 22, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

耐火性与耐药性侵入性阿斯伯吉洛症相比

Maiken Cavling Arendrup^1,2, Catherine Cordonnier³

¹Unit of Mycology, Statens Serum Institut, Building 45, room 123, Artillerivej 5, DK-2300 Copenhagen, Denmark.

The Journal of antimicrobial chemotherapy

|March 14, 2025

概括

由于宿主,真菌和治疗因素,管理侵入性阿斯伯吉洛症 (IA) 是复杂的. 早期评估治疗失败对于有效的患者管理和改善IA病例的结果至关重要.

科学领域:

菌类学菌类学是指菌类学.
传染性疾病传染性疾病
临床医学临床医学

背景情况:

侵入性阿斯伯吉洛症 (IA) 管理具有挑战性,因为治疗经常失败.
患者的结果取决于宿主因素,真菌特征和治疗干预措施.
在IA中评估治疗失败是复杂的,但对于指导患者护理至关重要.

研究的目的:

审查定义和评估和管理临床折射性或侵袭性阿斯伯吉洛症失败的方法.
突出IA治疗结果的多因素性质.
讨论耐药性和诊断及时性对IA管理的影响.

主要方法:

关于侵袭性阿斯伯吉洛症管理和治疗失败的文献综述.
对IA治疗结果有助于治疗的因素的分析.
讨论诊断进步和在阿斯伯吉勒斯物种中检测耐药性的讨论.

主要成果:

在IA中治疗失败受到潜在疾病严重程度,真菌易感性和治疗特征的影响.
折射性可能源于各种因素,包括低于最佳的药物暴露和真正的耐药性.
即使在没有阿佐尔的患者中,在Aspergillus fumigatus中增加阿佐尔耐药性也构成了重大挑战.

结论:

有效的IA管理需要对宿主,病原体和治疗因素进行全面评估.
及时诊断和敏感性报告对于适应IA治疗至关重要.
解决IA治疗失败的挑战对于改善患者存活率至关重要.

更多相关视频

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...